403 related articles for article (PubMed ID: 21555586)
1. Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells.
Itoh M; Kiuru M; Cairo MS; Christiano AM
Proc Natl Acad Sci U S A; 2011 May; 108(21):8797-802. PubMed ID: 21555586
[TBL] [Abstract][Full Text] [Related]
2. Establishment of integration-free induced pluripotent stem cells from human recessive dystrophic epidermolysis bullosa keratinocytes.
Matsumura W; Fujita Y; Nakayama C; Shinkuma S; Suzuki S; Nomura T; Abe R; Shimizu H
J Dermatol Sci; 2018 Mar; 89(3):263-271. PubMed ID: 29229433
[TBL] [Abstract][Full Text] [Related]
3. Generation of 3D skin equivalents fully reconstituted from human induced pluripotent stem cells (iPSCs).
Itoh M; Umegaki-Arao N; Guo Z; Liu L; Higgins CA; Christiano AM
PLoS One; 2013; 8(10):e77673. PubMed ID: 24147053
[TBL] [Abstract][Full Text] [Related]
4. Genetically corrected iPSCs as cell therapy for recessive dystrophic epidermolysis bullosa.
Wenzel D; Bayerl J; Nyström A; Bruckner-Tuderman L; Meixner A; Penninger JM
Sci Transl Med; 2014 Nov; 6(264):264ra165. PubMed ID: 25429058
[TBL] [Abstract][Full Text] [Related]
5. The development of induced pluripotent stem cell-derived mesenchymal stem/stromal cells from normal human and RDEB epidermal keratinocytes.
Nakayama C; Fujita Y; Matsumura W; Ujiie I; Takashima S; Shinkuma S; Nomura T; Abe R; Shimizu H
J Dermatol Sci; 2018 Sep; 91(3):301-310. PubMed ID: 29933899
[TBL] [Abstract][Full Text] [Related]
6. Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system.
Itoh M; Kawagoe S; Tamai K; Nakagawa H; Asahina A; Okano HJ
J Dermatol Sci; 2020 Jun; 98(3):163-172. PubMed ID: 32376152
[TBL] [Abstract][Full Text] [Related]
7. Induced pluripotent stem cells from human revertant keratinocytes for the treatment of epidermolysis bullosa.
Umegaki-Arao N; Pasmooij AM; Itoh M; Cerise JE; Guo Z; Levy B; Gostyński A; Rothman LR; Jonkman MF; Christiano AM
Sci Transl Med; 2014 Nov; 6(264):264ra164. PubMed ID: 25429057
[TBL] [Abstract][Full Text] [Related]
8. Inside out: regenerative medicine for recessive dystrophic epidermolysis bullosa.
Vanden Oever M; Twaroski K; Osborn MJ; Wagner JE; Tolar J
Pediatr Res; 2018 Jan; 83(1-2):318-324. PubMed ID: 29593249
[TBL] [Abstract][Full Text] [Related]
9. Generation of 3D Skin Organoid from Cord Blood-derived Induced Pluripotent Stem Cells.
Kim Y; Ju JH
J Vis Exp; 2019 Apr; (146):. PubMed ID: 31058887
[TBL] [Abstract][Full Text] [Related]
10. Melanin Transfer in Human 3D Skin Equivalents Generated Exclusively from Induced Pluripotent Stem Cells.
Gledhill K; Guo Z; Umegaki-Arao N; Higgins CA; Itoh M; Christiano AM
PLoS One; 2015; 10(8):e0136713. PubMed ID: 26308443
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
[TBL] [Abstract][Full Text] [Related]
12. Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa.
Tolar J; Xia L; Riddle MJ; Lees CJ; Eide CR; McElmurry RT; Titeux M; Osborn MJ; Lund TC; Hovnanian A; Wagner JE; Blazar BR
J Invest Dermatol; 2011 Apr; 131(4):848-56. PubMed ID: 21124339
[TBL] [Abstract][Full Text] [Related]
13. Reprogramming of Keratinocytes as Donor or Target Cells Holds Great Promise for Cell Therapy and Regenerative Medicine.
Zhang Y; Hu W; Ma K; Zhang C; Fu X
Stem Cell Rev Rep; 2019 Oct; 15(5):680-689. PubMed ID: 31197578
[TBL] [Abstract][Full Text] [Related]
14. Direct conversion of mouse embryonic fibroblasts into functional keratinocytes through transient expression of pluripotency-related genes.
Iacovides D; Rizki G; Lapathitis G; Strati K
Stem Cell Res Ther; 2016 Jul; 7(1):98. PubMed ID: 27473056
[TBL] [Abstract][Full Text] [Related]
15. Generation of Keratinocytes from Human Induced Pluripotent Stem Cells Under Defined Culture Conditions.
Sah SK; Kanaujiya JK; Chen IP; Reichenberger EJ
Cell Reprogram; 2021 Feb; 23(1):1-13. PubMed ID: 33373529
[TBL] [Abstract][Full Text] [Related]
16. Base Editor Correction of COL7A1 in Recessive Dystrophic Epidermolysis Bullosa Patient-Derived Fibroblasts and iPSCs.
Osborn MJ; Newby GA; McElroy AN; Knipping F; Nielsen SC; Riddle MJ; Xia L; Chen W; Eide CR; Webber BR; Wandall HH; Dabelsteen S; Blazar BR; Liu DR; Tolar J
J Invest Dermatol; 2020 Feb; 140(2):338-347.e5. PubMed ID: 31437443
[TBL] [Abstract][Full Text] [Related]
17. The utility of dermal fibroblasts in treatment of skin disorders: A paradigm of recessive dystrophic epidermolysis bullosa.
Shams F; Rahimpour A; Vahidnezhad H; Hosseinzadeh S; Moravvej H; Kazemi B; Rajabibazl M; Abdollahimajd F; Uitto J
Dermatol Ther; 2021 Jul; 34(4):e15028. PubMed ID: 34145697
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a complex skin structure via layered co-culture of keratinocytes and fibroblasts derived from induced pluripotent stem cells.
Kim Y; Park N; Rim YA; Nam Y; Jung H; Lee K; Ju JH
Stem Cell Res Ther; 2018 Aug; 9(1):217. PubMed ID: 30103800
[TBL] [Abstract][Full Text] [Related]
19. Revertant mosaic fibroblasts in recessive dystrophic epidermolysis bullosa.
Twaroski K; Eide C; Riddle MJ; Xia L; Lees CJ; Chen W; Mathews W; Keene DR; McGrath JA; Tolar J
Br J Dermatol; 2019 Dec; 181(6):1247-1253. PubMed ID: 30924923
[TBL] [Abstract][Full Text] [Related]
20. From skin to the treatment of diseases--the possibilities of iPS cell research in dermatology.
Galach M; Utikal J
Exp Dermatol; 2011 Jun; 20(6):523-8. PubMed ID: 21585557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
